# A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients

> **NCT02572947** · PHASE2 · COMPLETED · sponsor: **Calmy Alexandra** · enrollment: 8 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Dolutegravir
- Monotherapy
- Treatment Efficacy

## Interventions

- **DRUG:** Dolutegravir

## Key facts

- **NCT ID:** NCT02572947
- **Lead sponsor:** Calmy Alexandra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572947, "A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02572947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*